HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Craniopharyngioma

Craniopharyngioma is a rare type of brain tumor that typically occurs near the pituitary gland, a small endocrine gland at the base of the brain. This tumor is often benign but can cause significant health issues due to its location and impact on surrounding structures. These tumors develop from embryonic tissue remnants and are most commonly diagnosed in children and adolescents, although they can also affect adults. The exact cause of craniopharyngiomas is not well understood. Symptoms of craniopharyngioma can vary but often include headaches, vision problems, hormonal imbalances, and behavioral changes. The tumor's proximity to the pituitary gland can lead to disruptions in hormone production, affecting growth, puberty, and overall endocrine function. Treatment options for craniopharyngioma may involve surgical removal, radiation therapy, or a combination of both. The choice of treatment depends on factors such as the tumor size, location, and the individual's overall health. Despite being generally slow-growing and benign, craniopharyngiomas can be challenging to manage due to their location near critical structures in the brain. Long-term follow-up care is often necessary to monitor for potential recurrences or complications, and hormonal replacement therapy may be required to address endocrine deficiencies caused by the tumor or its treatment. In conclusion, craniopharyngioma is a rare brain tumor with potential serious consequences due to its impact on hormonal and neurological functions. Timely diagnosis and appropriate treatment are crucial for managing this condition and improving the patient's overall quality of life.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp